6ZC9 image
Entry Detail
PDB ID:
6ZC9
Title:
Structure of 14-3-3 gamma in complex with Nedd4-2 14-3-3 binding motif Ser448
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2020-06-10
Release Date:
2021-07-21
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
H 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:14-3-3 protein gamma
Mutations:S235Stop
Chain IDs:A, B, C, D
Chain Length:234
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:E3 ubiquitin-protein ligase NEDD4-like
Chain IDs:E, F, G, H
Chain Length:10
Number of Molecules:4
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP E SER modified residue
Ligand Molecules
Primary Citation
14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains.
Commun Biol 4 899 899 (2021)
PMID: 34294877 DOI: 10.1038/s42003-021-02419-0

Abstact

Neural precursor cell expressed developmentally down-regulated 4 ligase (Nedd4-2) is an E3 ubiquitin ligase that targets proteins for ubiquitination and endocytosis, thereby regulating numerous ion channels, membrane receptors and tumor suppressors. Nedd4-2 activity is regulated by autoinhibition, calcium binding, oxidative stress, substrate binding, phosphorylation and 14-3-3 protein binding. However, the structural basis of 14-3-3-mediated Nedd4-2 regulation remains poorly understood. Here, we combined several techniques of integrative structural biology to characterize Nedd4-2 and its complex with 14-3-3. We demonstrate that phosphorylated Ser342 and Ser448 are the key residues that facilitate 14-3-3 protein binding to Nedd4-2 and that 14-3-3 protein binding induces a structural rearrangement of Nedd4-2 by inhibiting interactions between its structured domains. Overall, our findings provide the structural glimpse into the 14-3-3-mediated Nedd4-2 regulation and highlight the potential of the Nedd4-2:14-3-3 complex as a pharmacological target for Nedd4-2-associated diseases such as hypertension, epilepsy, kidney disease and cancer.

Legend

Protein

Chemical

Disease

Primary Citation of related structures